Thursday, 15 October 2026European Markets

SPAREBANK 1 SØRØ, TIKEHAU CAPITAL, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - sparebank 1 sørø (soon.ol) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
sparebank 1 sørø (soon.ol) kr66.23 5.75% 10.62%
tikehau capital (tko.pa) €20.35 3.46% 5.57%
peugeot invest (peug.pa) €117.00 3.07% 3.29%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. sparebank 1 sørø (soon.ol)

5.75% forward dividend yield and 10.62% return on equity

sparebank 1 sørøst-norge provides various banking products and services for private and corporate customers in norway. the company offers mobile and online banking, card, account, and payment services. it also provides mortgage, car, boat, consumer, and other vehicle loans as well as refinancing, micro savings, investment, pension, and property related services. in addition, the company offers daily operations, get paid, loans and financing, and pension related products. further, it provides business and personnel insurance as well as savings and investment products. the company was founded in 1859 and is headquartered in sandefjord, norway.

earnings per share

as for profitability, sparebank 1 sørø has a trailing twelve months eps of kr5.47.

pe ratio

sparebank 1 sørø has a trailing twelve months price to earnings ratio of 12.11. meaning, the purchaser of the share is investing kr12.11 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.62%.

revenue growth

year-on-year quarterly revenue growth grew by 12.1%, now sitting on 3.13b for the twelve trailing months.

growth estimates quarters

the company's growth estimates for the present quarter and the next is 27.3% and 18%, respectively.

more news about sparebank 1 sørø.

2. tikehau capital (tko.pa)

3.46% forward dividend yield and 5.57% return on equity

tikehau capital is a private equity and venture capital firm specializing in providing a full range of financing products including senior secured loans, equity, senior debt, unitranche, mezzanine, and preferred shares. the firm seeks to make early stage, mezzanine, and turnaround investments and manage long-term capital for institutional and private investors in various asset classes including credit, listed, private equity, and real estate. it invests in all sectors and all countries with a focus on singapore. the firm prefers to make equity investment between €10 million ($10.88 million) and €200 million ($217.55 million), in companies with sales value between €20 million ($21.75 million) and €1 billion ($1087.73 million). the firm seeks to invest in small and middle market european corporate. it makes balance sheet investments. tikehau capital was founded in june 2004 and is based in paris, france with additional offices across middle east, europe, north america, and asia.

earnings per share

as for profitability, tikehau capital has a trailing twelve months eps of €0.98.

pe ratio

tikehau capital has a trailing twelve months price to earnings ratio of 20.77. meaning, the purchaser of the share is investing €20.77 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.57%.

volatility

tikehau capital's last week, last month's, and last quarter's current intraday variation average was a negative 0.30%, a positive 0.09%, and a positive 1.00%.

tikehau capital's highest amplitude of average volatility was 1.47% (last week), 0.90% (last month), and 1.00% (last quarter).

yearly top and bottom value

tikehau capital's stock is valued at €20.35 at 07:30 est, way below its 52-week high of €24.10 and higher than its 52-week low of €18.74.

more news about tikehau capital.

3. peugeot invest (peug.pa)

3.07% forward dividend yield and 3.29% return on equity

peugeot invest société anonyme operates as an investment company. the firm invests in private equity and real estate funds. the firm also invests in governance, social, and environmental protection. the company was formerly known as ffp société anonyme and changed its name to peugeot invest société anonyme. peugeot invest société anonyme was incorporated in 1929 and is headquartered in paris, france.

earnings per share

as for profitability, peugeot invest has a trailing twelve months eps of €11.95.

pe ratio

peugeot invest has a trailing twelve months price to earnings ratio of 9.79. meaning, the purchaser of the share is investing €9.79 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.29%.

moving average

peugeot invest's worth is above its 50-day moving average of €110.59 and way higher than its 200-day moving average of €103.20.

yearly top and bottom value

peugeot invest's stock is valued at €117.00 at 07:30 est, under its 52-week high of €119.60 and way higher than its 52-week low of €88.90.

more news about peugeot invest.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com